In this PPI network genes such as myoD family inhibitor (MDFI), CCT6A, RPS14 and DPY19L2 were predicted as novel prognostic or diagnostic biomarkers and new therapeutic target in CAD. Here, CCT6A is linked to coronary artery disorder.